Who's buying pet
brands in 2026.

Pet is the quiet giant of consumer. While DTC founders argue about paid social and apparel brands fight markdown cycles, pet owners keep spending through every downturn, and the acquirers noticed. In 2026 the deals came fast: a vet-clinic roll-up, a fresh-food carve-out, a Japanese group buying its way into Brazil, and a string of premium brands changing hands.

Here's the anchor. In 2025, Americans spent $158 billion on their pets, up 3.7 percent, and the American Pet Products Association projects $165 billion for 2026. Food and treats alone are $68.3 billion of that, ahead of vet care at $41.0 billion. Globally, Bloomberg Intelligence projects the pet economy will reach $500 billion by 2030. This is a large, durable, recession-resistant market, and that is exactly the profile a strategic acquirer likes to buy.

I've sat on the side of the table that sets these numbers. At WIN Brands Group we built consumer brands and bought brands to fold into the portfolio, which means I've run the quality-of-earnings work that takes a founder's reported numbers apart line by line. Pet is a consumer category like any other on the buy side: the multiple is a proxy for margin, repeat purchase, and how defensible the brand is once the founder leaves.

This is the long version. Who's actually acquiring pet brands in 2026, a ledger of the real deals, the three camps that price you differently, why fresh and premium keep getting bought, what a pet brand sells for, and what earns a premium. Every figure is grounded in disclosed deals and published data. Where terms were not officially disclosed, I say so, because most private pet deals close quietly and the headline valuations are reported, not confirmed.

A $158B market,
and deals back
to a 2026 pace.

Pet-sector dealmaking accelerated hard into 2026. Capstone Partners' April 2026 pet-sector update counted 18 announced or completed transactions year to date, versus 8 in the same window a year earlier, split across vet and health, food, and services. Strategic buyers drove 10 of those 18, up from 3 a year earlier, and private equity added 8 through 3 platforms and 5 add-ons. The buyers came back, and the corporates set the pace.

That is a rebound, not a boom, and the distinction matters. Pet food M&A specifically had cooled in 2025 to 23 deals, down from 26 in 2024, per Petfood Industry's tracking. What changed in 2026 is who is buying and what they want: fewer opportunistic roll-ups, more deliberate moves by large consumer companies into the premium and health corners of the category. When General Mills, Colgate, and Chewy all write checks in the same window, that is a signal about where the margin is going.

The underlying demand is what makes pet a safe place to deploy capital. Roughly 95 million US households own a pet, per the APPA's National Pet Owners Survey, and spending held up through the inflation of the last few years. A category that grows regardless of the macro, with a customer who treats the product as non-discretionary, is a category acquirers will keep paying to enter.

The pet deals
that actually
got done.

Here is the 2026 ledger, plus the two 2024 to 2025 anchors that set it up. The pattern is clear at a glance: strategics and consumer-goods groups buying premium and fresh, private equity buying platforms, and only a handful of prices officially disclosed. Where a figure is reported by trade or financial press rather than confirmed by the parties, it says so, because for a founder the difference between a confirmed number and a rumored one is the whole negotiation.

Two things stand out. First, the big confirmed number is General Mills paying $1.45 billion for Whitebridge's premium cat and treats business, a clean read on what a large CPG will pay for the fastest-growing corner of pet. Second, most of the 2026 deals close without a price, which is normal for private consumer M&A and a reminder that the exit tracker matters more than the press release. You can see the same pattern across categories in the consumer exits tracker and the acquirer map.

The three camps
buying pet, and
what each wants.

The pet buyer pool sorts into three camps, and the camp that buys you shapes your number more than the brand itself. The same fresh-food brand is worth a strategic premium to one buyer and a cash-flow multiple to another, because they are underwriting different things.

The first camp is the strategic consumer-goods acquirers: General Mills, Colgate-Palmolive, Nestle, and the pet majors. They buy premium and health brands to bolt onto distribution they already own, and they pay up for the fastest-growing, highest-margin corners as their legacy lines mature. General Mills entered pet with Blue Buffalo in 2018 and kept adding, and the $1.45 billion Whitebridge deal is the same playbook: buy premium cat and natural treats, plug into the machine.

The second camp is private equity and platform aggregators. They underwrite to EBITDA and cash flow, which usually means a lower revenue multiple than a strategic would pay for the identical brand. Partners Group's roughly £400 million buyout of Applaws maker MPM Products, bought from 3i, shows PE still treats premium pet food as a durable platform, not a quick flip. If a financial buyer is your likely acquirer, your clean, defensible profit matters more than your growth story.

The third camp is the channel and DTC players: Chewy building a vertically integrated pet-health ecosystem, and fresh-food groups buying direct brands outright. Chewy's Modern Animal deal added 29 vet clinics and lifts its clinic footprint toward 47 locations, so it can own the vet relationship and cross-sell food, pharmacy, and insurance. Agrolimen buying Ollie is the same logic from the food side: acquire a proven fresh-DTC engine rather than build one. Knowing which camp is your buyer tells you what to make undeniable, the same discipline behind the diligence red flags that make a buyer walk.

Humanization is
why premium and
fresh keep selling.

One idea sits under almost every pet deal in the ledger: humanization. In a 2023 Pew Research Center survey, 51 percent of US pet owners said their pets are as much a part of their family as a human member, and 62 percent of Americans own a pet. When people treat the animal like family, they trade up to fresh, premium, and health-forward products, and that is exactly the corner acquirers are buying.

The deals track the thesis precisely. Colgate's Hill's franchise is built on prescription and science-led dry food, and its Prime100 acquisition was a deliberate move into fresh and single-protein, the category DTC brands like The Farmer's Dog and Ollie have been winning. General Mills bought premium cat and natural treats. Agrolimen bought a fresh-DTC leader. Nobody in this cycle is paying a premium for commodity kibble.

For a founder, the read is simple. If your brand sits in the premium, fresh, or functional-health lane with real repeat purchase, you are in the part of pet that gets bid. If you compete on price in the mainstream aisle, you are in the part that gets consolidated at a cash-flow multiple. The category is generous to brands that earned a place in the "family member" budget, and unforgiving to the ones that did not.

What a pet brand
actually sells
for in 2026.

Start with the honest caveat: most pet deals in 2026 closed without disclosed terms, so anyone quoting a precise category multiple is guessing. What we can anchor to is the confirmed scale and the reported valuations. General Mills paid a confirmed $1.45 billion for Whitebridge. Umios paid a confirmed ~$70 million for 51 percent of Pet World International. Ollie was reported above $600 million, and Prime100 near $317.5 million, both unconfirmed by the parties.

The clearest benchmark is the DTC leader that has not sold. The Farmer's Dog was running near $1.2 billion in annualized net revenue with $10 million-plus in monthly profit by early 2025, per PitchBook, on a last confirmed valuation of $1.46 billion from its 2021 round. A more recent $3.5 billion valuation has circulated in trade press but is not confirmed, so treat the $1.46 billion as the hard number. For public scale, fresh-food peer Freshpet recorded $975.2 million in net sales in 2024.

The practical takeaway is that scale plus profit is what commands a real price in pet, not growth alone. A fresh or premium brand with genuine repeat purchase and improving margins is having a very different conversation than a fast-growing brand still buying its revenue. Pet rewards the same thing every consumer category rewards on the buy side: durable, defensible unit economics that survive the founder leaving.

What earns a
premium in a
pet acquisition.

An acquirable pet brand does four things well: it sits in a premium or health lane the majors want, it has real repeat purchase rather than one-time trial, it runs clean margins a diligence process can defend, and it operates without depending on its founder. Do those and you have a choice of buyers across all three camps, which is what actually sets the price. A brand with one likely acquirer takes whatever that buyer offers.

The move for a founder is to decide which camp you are building for and make that brand undeniable. If it is a strategic, invest in the premium positioning and the shelf and channel a CPG can plug in. If it is Chewy or a fresh-food group, invest in the direct engine and the subscription repeat that proves durable demand. If it is private equity, invest in clean, growing margins and a balance sheet without surprises. Either way, the work happens years before the process, and it shows up in the deals that got done.

The category is in your favor if you build for it. Pet spending is large, durable, and trading up, the acquirers are active, and the thesis rewards exactly the brands that treat the animal like the family member their customers already believe it is. If you want a live read on what your brand might clear, the exits tracker and the series companion on who's buying apparel brands keep the current comps in one place.